Skip to Content

Regenetp Inc RGTPQ

Morningstar Rating
$0.19 −0.03 (14.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RGTPQ is trading at a 581% premium.
Price
$0.19
Fair Value
$3.17
Uncertainty
Extreme
1-Star Price
$8.58
5-Star Price
$8.82
Economic Moat
Ynfw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RGTPQ is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.22
Day Range
$0.190.22
52-Week Range
$0.010.22
Bid/Ask
$0.08 / $0.11
Market Cap
$1.37 Mil
Volume/Avg
1,855 / 16,380

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
44

Valuation

Metric
RGTPQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
RGTPQ
Quick Ratio
3.15
Current Ratio
4.11
Interest Coverage
Quick Ratio
RGTPQ

Profitability

Metric
RGTPQ
Return on Assets (Normalized)
−75.12%
Return on Equity (Normalized)
−108.54%
Return on Invested Capital (Normalized)
−97.50%
Return on Assets
RGTPQ
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
TmvqqwtwgFyqt$584.2 Bil
Vertex Pharmaceuticals Inc
VRTX
CjvkfhdpRpxzgz$126.7 Bil
Regeneron Pharmaceuticals Inc
REGN
HpbtsxfzPvfnsk$116.9 Bil
Moderna Inc
MRNA
CmysqxjWml$45.3 Bil
Alnylam Pharmaceuticals Inc
ALNY
HkpwpbqgSdksps$29.9 Bil
argenx SE ADR
ARGX
GgyndmkctTsj$27.8 Bil
BioNTech SE ADR
BNTX
ZfbpxgvqsMfrs$20.0 Bil
Biomarin Pharmaceutical Inc
BMRN
KgkpvfxqVfcybd$16.1 Bil
United Therapeutics Corp
UTHR
QvqlvhySfcwy$14.7 Bil
Incyte Corp
INCY
PvmlzkvnqPyhvwmc$13.2 Bil

Sponsor Center